bromocriptine and remoxipride
bromocriptine has been researched along with remoxipride in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boulton, AA; Juorio, AV; Paterson, IA; Zhu, MY | 1 |
| Ahangari, G; Deezagi, A; Hejazi, SH; Pornour, M | 1 |
| Ahangari, G; Bakhtou, H; Deezagi, A; Olfatbakhsh, A | 1 |
Other Studies
3 other study(ies) available for bromocriptine and remoxipride
| Article | Year |
|---|---|
Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.
Topics: Animals; Antipsychotic Agents; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dextroamphetamine; Dopamine D2 Receptor Antagonists; Drug Interactions; Ergolines; Flupenthixol; Male; Pimozide; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Stereoisomerism | 1993 |
New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Bromocriptine; Cell Survival; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Patents as Topic; Proliferating Cell Nuclear Antigen; Receptors, Dopamine D2; Remoxipride | 2015 |
The Expression of Dopamine Receptors Gene and their Potential Role in Targeting Breast Cancer Cells with Selective Agonist and Antagonist Drugs. Could it be the Novel Insight to Therapy?
Topics: Adult; Apoptosis; Breast Neoplasms; Bromocriptine; Cabergoline; Cell Line, Tumor; Cell Proliferation; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Leukocytes, Mononuclear; Middle Aged; Neoplasm Staging; Receptors, Dopamine; Receptors, Estrogen; Receptors, Progesterone; Remoxipride | 2019 |